Attached files

file filename
10-K - 090630_IMX_FORM 10K - SECURE POINT TECHNOLOGIES INCimxform10k_090630.htm
EX-3.1 - 090630_IMX_FORM 10K_EX 3.1 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex3-1.htm
EX-23.1 - 090630_IMX_FORM 10K_EX 23.1 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex23-1.htm
EX-31.2 - 090630_IMX_FORM 10K_EX 31.2 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex31-2.htm
EX-31.1 - 090630_IMX_FORM 10K_EX 31.1 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex31-1.htm
EX-32.2 - 090630_IMX_FORM 10K_EX 32.2 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex32-2.htm
EX-21 - 090630_IMX_FORM 10K_EX 21 - SECURE POINT TECHNOLOGIES INCimxform10k090630_ex21.htm


Exhibit 32.1
 
 
In connection with the Annual Report of Implant Sciences Corporation., a Massachusetts corporation (the “Company”), on Form 10-K for the fiscal year ended June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Glenn D. Bolduc, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
 
(1)       The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Glenn D. Bolduc
 
Glenn D Bolduc
 
President, Chief Executive Officer and Chief Financial Officer
Date: October 9, 2009
 
   

 
This certification accompanies each report of the Company on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.
 
A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.